These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23441834)

  • 21. Non-speech oro-motor exercises in post-stroke dysarthria intervention: a randomized feasibility trial.
    Mackenzie C; Muir M; Allen C; Jensen A
    Int J Lang Commun Disord; 2014; 49(5):602-17. PubMed ID: 24889103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual and environmental contributions to treatment outcomes following a neuroplasticity-principled speech treatment (LSVT LOUD) in children with dysarthria secondary to cerebral palsy: a case study review.
    Boliek CA; Fox CM
    Int J Speech Lang Pathol; 2014 Aug; 16(4):372-85. PubMed ID: 25011399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptual and Acoustic Effects of Dual-Focus Speech Treatment in Children With Dysarthria.
    Levy ES; Chang YM; Hwang K; McAuliffe MJ
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2301-2316. PubMed ID: 33656916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Data-Driven Classification of Dysarthria Profiles in Children With Cerebral Palsy.
    Allison KM; Hustad KC
    J Speech Lang Hear Res; 2018 Dec; 61(12):2837-2853. PubMed ID: 30481827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Parker NK; Kelly H; Miller N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROMPT to improve speech motor abilities in children with cerebral palsy: a wait-list control group trial protocol.
    Fiori S; Ragoni C; Podda I; Chilosi A; Amador C; Cipriani P; Guzzetta A; Sgandurra G
    BMC Neurol; 2022 Jul; 22(1):246. PubMed ID: 35794522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability and Diagnostic Accuracy of Speech Intelligibility Scores in Children.
    Hustad KC; Oakes A; Allison K
    J Speech Lang Hear Res; 2015 Dec; 58(6):1695-707. PubMed ID: 26381119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of strategies to increase speech intelligibility in cerebral palsy: an experimental evaluation.
    Hunter L; Pring T; Martin S
    Br J Disord Commun; 1991 Aug; 26(2):163-74. PubMed ID: 1777397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acoustic and Perceptual Consequences of Speech Cues for Children With Dysarthria.
    Levy ES; Chang YM; Ancelle JA; McAuliffe MJ
    J Speech Lang Hear Res; 2017 Jun; 60(6S):1766-1779. PubMed ID: 28655046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementing speech supplementation strategies: effects on intelligibility and speech rate of individuals with chronic severe dysarthria.
    Hustad KC; Jones T; Dailey S
    J Speech Lang Hear Res; 2003 Apr; 46(2):462-74. PubMed ID: 14700386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy.
    Leary SM; Gilpin P; Lockley L; Rodriguez L; Jarrett L; Stevenson VL
    Clin Rehabil; 2006 Mar; 20(3):228-31. PubMed ID: 16634341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speech Treatment Effects on Narrative Intelligibility in French-Speaking Children With Dysarthria.
    Moya-Galé G; Keller B; Escorial S; Levy ES
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2154-2168. PubMed ID: 33719503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial comparing Parent Led Therapist Supervised Articulation Therapy (PLAT) with routine intervention for children with speech disorders associated with cleft palate.
    Sweeney T; Hegarty F; Powell K; Deasy L; Regan MO; Sell D
    Int J Lang Commun Disord; 2020 Sep; 55(5):639-660. PubMed ID: 32725861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of The Viking Speech Scale to classify the speech of children with cerebral palsy.
    Pennington L; Virella D; Mjøen T; da Graça Andrada M; Murray J; Colver A; Himmelmann K; Rackauskaite G; Greitane A; Prasauskiene A; Andersen G; de la Cruz J
    Res Dev Disabil; 2013 Oct; 34(10):3202-10. PubMed ID: 23891732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alignment of classification paradigms for communication abilities in children with cerebral palsy.
    Hustad KC; Oakes A; McFadd E; Allison KM
    Dev Med Child Neurol; 2016 Jun; 58(6):597-604. PubMed ID: 26521844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural intervention effects in dysarthria following stroke: communication effectiveness, intelligibility and dysarthria impact.
    Mackenzie C; Lowit A
    Int J Lang Commun Disord; 2007; 42(2):131-53. PubMed ID: 17365091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.